Acetaminophen research
This article was originally published in The Tan Sheet
Executive Summary
High doses of analgesic clear "rapidly and completely" from the bloodstream, researchers state at Society of Toxicology annual meeting in Salt Lake City. "Analysis of plasma acetaminophen levels showed that doses as high as 8 g/day, or twice the maximum daily recommended dose, did not accumulate and the drug was consistently cleared from the bloodstream," according to McNeil's Cathy Gelotte, PhD. Double-blind, placebo-controlled study divided 36 participants into three groups with dosing regimens of 4 g/d, 6 g/d or 8 g/d for three days. Participants underwent blood sampling during the first and last dose of each daily regimen, Gelotte reports. NDAC members recently advised acetaminophen labeling changes to clarify potential for liver toxicity (1"The Tan Sheet" Sept. 23, 2002, p. 4)...
You may also be interested in...
Acetaminophen “Black Box” Warning Would “Scare” Users, NDAC Rep Says
Use of a "black box" warning on OTC acetaminophen labeling would be an inappropriate means for alerting consumers about potential liver damage, two consultants to FDA's Nonprescription Drugs Advisory Committee said Sept. 19
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.